Carcinogenicity studies of 1,4-dioxane administered in drinking-water to rats and mice for 2 years

Food and Chemical Toxicology

Volumn 47, Issue 11, 2009, Pages 2776-2784

  Kano, Hirokazu ^a   Umeda, Yumi ^a   Kasai, Tatsuya ^a   Sasaki, Toshiaki ^a   Matsumoto, Michiharu ^a   Yamazaki, Kazunori ^a   Nagano, Kasuke ^a   Arito, Heihachiro ^a   Fukushima, Shoji ^a  

^a JAPAN INDUSTRIAL SAFETY AND HEALTH ASSOCIATION   (Japan)

Author keywords

1,4 Dioxane; Liver; Mouse; Nasal cavity; Rat; Tumor

Indexed keywords

DIOXANE; DRINKING WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOMA; CANCER RISK; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; LIVER ADENOMA; LIVER CELL CARCINOMA; LONG TERM EXPOSURE; MALE; MOUSE; NONHUMAN; NOSE CARCINOMA; PERITONEUM MESOTHELIOMA; RAT; SQUAMOUS CELL CARCINOMA; WATER CONTAMINATION;

ANIMALS; CARCINOGENS; DIOXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; LONGEVITY; MALE; MICE; RATS; RATS, INBRED F344; SEX CHARACTERISTICS;

MUS; RATTUS;

EID: 70350189964     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.08.012     Document Type: Article

References (56)

1. Acheson E.D. Nasal cancer in the furniture and boot and shoe manufacturing industries. Preventive Medicine 5 (1976) 295-315
2. Acheson E.D., Cowdell R.H., Hadfield E., and Macbeth R.G. Nasal cancer in woodworkers in the furniture industry. British Medical Journal 2 (1968) 587-596
3. Argus M.F., Arcos J.C., and Hoch-Ligeti C. Studies on the carcinogenic activity of protein-denaturing agents: hepatocarcinogenicity of dioxane. Journal of the National Cancer Institute 35 (1965) 949-958
4. Argus M.F., Sohal R.S., Bryant G.M., Hoch-Ligeti C., and Arcos J.C. Dose-response and ultrastructural alterations in dioxane carcinogenesis. Influence of methylcholanthrene on acute toxicity. European Journal of Cancer 9 (1973) 237-243
5. ATSDR (Agency for Toxic Substances and Disease Registry), 2007. Toxicological profile for 1,4-dioxane. Draft for public comment. US Department of Health and Human Services. (site visited on March 13, 2009).
6. Bannasch P., Griesemer R.A., Anders F., Becker R., Cabral J.R., Della Porta G., Feron V.J., Henschler D., Ito N., Kroes R., Magee P.N., McKnight B., Mohr U., Montesano R., Napalkov N.P., Nesnow S., Pegg A.E., Rao G.N., Turusov V.S., Wahrendorf J., and Wilbourn J. Long-term assays for carcinogenicity in animals. In: Montesano R., Bartsch H., Vainio H., Wilbourn J., and Yamasaki H. (Eds). Long-term and Short-term Assays for Carcinogens: A Critical Appraisal. IARC Scientific Publications No. 83 (1986), IARC, Lyon, France 13-83
7. Bond J.A. Metabolism of xenobiotics by the respiratory tract. In: Gardner D.E., Crapo J.D., and McClellan R.O. (Eds). Toxicology of the Lung. second ed. (1993), Raven Press, New York 187-215
8. Boorman G.A., Wilson J.TH., Zwieten M.J.V., and Eustis S.L. Mammary gland. In: Boorman G.A., Eustis S.L., Elwell M.R., Montgomery Jr. C.A., and MacKenzie W.F. (Eds). Pathology of the Fischer Rat (1990), Academic Press, San Diego, CA 295-313
9. Brown H.R. Neoplastic and potentially preneoplastic changes in the upper respiratory tract of rats and mice. Environmental Health Perspectives 85 (1990) 291-304
10. Buffler P.A., Wood S.M., Suarez L., and Kilian D.J. Mortality follow-up of workers exposed to 1,4-dioxane. Journal of Occupational Medicine 20 (1978) 255-259
11. Chemical Daily, 2008. 1,4-Dioxane. In: Chemical Products Handbook 15308. Chemical Daily Co. Ltd., Tokyo, pp. 825-826 (in Japanese).
12. Deschl U., Cattley R.C., Harada T., Küttler K., Hailey J.R., Hartig F., Leblanc B., Marsman D.S., and Shirai T. Liver, gallbladder, and exocrine pancreas. In: Mohr U. (Ed). International Classification of Rodent Tumors, The Mouse (2001), Springer-Verlag, Berlin 59-86
13. Elwell M.R., Stedham M.A., and Kovatch R.M. Skin and subcutis. In: Boorman G.A., Eustis S.L., Elwell M.R., Montgomery Jr. C.A., and MacKenzie W.F. (Eds). Pathology of the Fischer Rat (1990), Academic Press, San Diego, CA 261-277
14. European Chemicals Bureau. European Union Risk Assessment Report. Vol. 21, 1,4-Dioxane, European Communities (2002), Institute for Health and Consumer Protection, European Chemicals Bureau, Luxembourg
15. Fowlie A.J., Grasso P., and Benford D.J. The short-term effects of carcinogens and sulfur dioxide on the nuclear size of rat nasal epithelial cells. Journal of Applied Toxicology 10 (1990) 29-38
16. Gold L.S., Gaylor D.W., and Slone T.H. Comparison of cancer risk estimates based on a variety of risk assessment methodologies. Regulatory Toxicology and Pharmacology 37 (2003) 45-53
17. Goldsworthy T.L., Monticello T.M., Morgan K.T., Bermudez E., Wilson D.M., Jäckh R., and Butterworth B.E. Examination of potential mechanisms of carcinogenicity of 1,4-dioxane in rat nasal epithelial cells and hepatocytes. Archives of Toxicology 65 (1991) 1-9
18. Grant D., and Grasso P. Suppression of Hela cell growth and increase in nuclear size by chemical carcinogens: a possible screening method. Mutation Research 57 (1978) 369-380
19. Hall W.C. Peritoneum, retroperitoneum, mesentery, and abdominal cavity. In: Boorman G.A., Eustis S.L., Elwell M.R., Montgomery Jr. C.A., and MacKenzie W.F. (Eds). Pathology of the Fischer Rat (1990), Academic Press, San Diego, CA 63-69
20. Hoch-Ligeti C., Argus M.F., and Arcos J.C. Induction of carcinomas in the nasal cavity of rats by dioxane. British Journal of Cancer 24 (1970) 164-167
21. IARC. 1,4-Dioxine. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 71, Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide (1999), IARC, Lyon, France 589-602
22. Ito N., Imaida K., Asamoto M., and Shirai T. Early detection of carcinogenic substances and modifiers in rats. Mutation Research 462 (2000) 209-217
23. Japan Ministry of the Environment. Chemicals in the Environment, Fiscal Year 2001. Environmental Health and Safety Division (2002), Environmental Health Department, Japan Ministry of the Environment, Tokyo (in Japanese)
24. Japan Ministry of the Environment, 2008. Pollutant Release and Transfer Register, Fiscal Year 2006, Environmental Health and Safety Division, Environmental Health Department, Japan Ministry of the Environment. (in Japanese) (site visited on December 19, 2008).
25. Kano H., Umeda Y., Saito M., Senoh H., Ohbayashi H., Aiso S., Yamazaki K., Nagano K., and Fukushima S. Thirteen-week oral toxicity of 1,4-dioxane in rats and mice. The Journal of Toxicological Science 33 (2008) 141-153
26. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 53 (1958) 457-481
27. Kasai T., Kano H., Umeda Y., Sasaki T., Ikawa N., Nishizawa T., Nagano K., Arito H., Nagashima H., and Fukushima S. Two-year inhalation study of carcinogenicity and chronic toxicity of 1,4-dioxane in male rats. Inhalation Toxicology 21 (2009) 889-897
28. Kociba R.J., McCollister S.B., Park C., Torkelson T.R., and Gehring P.J. 1,4-Dioxane. I. Results of a 2-year ingestion study in rats. Toxicology and Applied Pharmacology 30 (1974) 275-286
29. Lewis R.J. Hawley's Condensed Chemical Dictionary. 12th ed. (1993), Van Nostrand Reinhold Co., New York p. 426
30. Mirkova E.T. Activity of the rodent carcinogen 1,4-dioxane in the mouse bone marrow micronucleus assay. Mutation Research 322 (1994) 142-144
31. Mohr U. International Classification of Rodent Tumours. Part Ι - The Rat. 10. Digestive System. IARC Scientific Publications No. 122 (1997), IARC, Lyon, France
32. Monticello T.M., Morgan K.T., and Uraih L. Nonneoplastic nasal lesions in rats and mice. Environmental Health Perspectives 85 (1990) 249-274
33. Morita T., and Hayashi M. 1,4-Dioxane is not mutagenic in five in vitro assays and mouse peripheral blood micronucleus assay, but is in mouse liver micronucleus assay. Environmental and Molecular Mutagenesis 32 (1998) 269-280
34. Nagano K., Katagiri T., Aiso S., Senoh H., Sakura Y., and Takeuchi T. Spontaneous lesions of nasal cavity in aging F344 rats and BDF1 mice. Experimental and Toxicologic Pathology 49 (1997) 97-104
35. Nannelli A., De Rubertis A., Long V., and Gervasi P.G. Effects of dioxane on cytochrome P450 enzymes in liver, kidney, lung and nasal mucosa of rat. Archives of Toxicology 79 (2005) 74-82
36. NCI, 1978. Bioassay of 1,4-dioxane for possible carcinogenicity. Technical Report Series No. 80. NCI-CG-TR-80. NCI, Bethesda, MD.
37. NRC (National Research Council), 1977. Guide for the Care and Use of Laboratory Animals. DHEW Publication No. (NIH) 11-23. Bethesda, MD.
38. OECD, 1981a. OECD Principles of Good Laboratory Practice. OECD, Paris. Adopted 1981.
39. OECD, 1981b. OECD Guideline for Testing of Chemicals 451, Carcinogenicity Studies. OECD, Paris. Adopted May 1981.
40. O'Neil M.J. The Merck Index. 14th ed. (2006), Merck & Co. Inc., Whitehouse Station, NJ p. 559
41. Peto R., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., Mantel N., McPherson K., Peto J., and Smith P.G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. British Journal of Cancer 35 (1977) 1-39
42. Peto, R., Pike, M.C., Day, N.E., Gray, R.G., Lee, P.N., Parish, S., Peto, J., Richards, S., Wahrendorf, J., 1980. Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. In: Long-term and Short-term Screening Assays for Carcinogens: A Critical Appraisal, IARC, Lyon, France. IARC Monogr. (Suppl. 2), 311-426.
43. Reitz R.H., McCroskey P.S., Park C.N., Andersen M.E., and Gargas M.L. Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxane. Toxicology and Applied Pharmacology 105 (1990) 37-54
44. Roy S.K., Thilagar A.K., and Eastmond D.A. Chromosome breakage is primarily responsible for the micronuclei induced by 1,4-dioxane in the bone marrow and liver of young CD-1 mice. Mutation Research 586 (2005) 28-37
45. Sontag J.M., Page N.P., and Saffiotti U. Guidelines for Carcinogen Bioassay in Small Rodents. NCI-CG-TR-1 (1976), NCI, Bethesda, MD
46. Sweeney L.M., Thrall K.D., Poet T.S., Corley R.A., Weber T.J., Locey B.J., Clarkson J., Sager S., and Gargas M.L. Physiologically based pharmacokinetic modeling of 1,4-dioxane in rats, mice and humans. Toxicological Sciences 101 (2008) 32-50
47. Torjussen W., Solberg L.A., and Høgetveit A.C. Histopathological changes of the nasal mucosa in active and retired nickel workers. British Journal of Cancer 40 (1979) 568-580
48. Torkelson T.R., Leong B.K.J., Kociba R.J., Richter W.A., and Gehring P.J. 1,4-Dioxane. II. Results of a 2-year inhalation study in rats. Toxicology and Applied Pharmacology 30 (1974) 287-298
49. US EPA. Proposed Guidelines for Carcinogen Risk Assessment. EPA 600/P-92/003C (1996), US EPA, Washington, DC
50. US EPA. Help Manual for Benchmark Dose Software Version 1.3. EPA 600/R-00/4F (2001), US EPA, Washington, DC
51. US EPA. Guidelines for Carcinogen Risk Assessment. Risk Assessment Forum. EPA/630/P-03/001B (2005), US EPA, Washington, DC
52. US EPA, 2008. 1,4-Dioxane, Integrated Risk Information System (IRIS). (site visited on March 13, 2009).
53. WHO. Environmental Health Criteria 104. Principles for the Toxicological Assessment of Pesticide Residues in Food. International Programme on Chemical Safety (1990), WHO, Geneva
54. WHO. Environmental Health Criteria 170. Assessing Human Health Risks of Chemicals: Derivation of Guidance Values for Health-based Exposure Limits. International Programme on Chemical Safety (1994), WHO, Geneva
55. WHO, 2008. Guidelines for Drinking-water Quality [Electronic Resource]: Incorporating 1st and 2nd Addenda, Vol. 1, Recommendations, third ed. (site visited on July 27, 2009).
56. Yamazaki, K., Ohno, H., Asakura, M., Narumi, A., Ohbayashi, H., Fujita, H., Ohnishi, M., Katagiri, T., Senoh, H., Yamanouchi, K., Nakayama, E., Yamamoto, S., Noguchi, T., Nagano, K., Enomoto, M., Sakabe, H., 1994. Two-year toxicological and carcinogenesis studies of 1,4-dioxane in F344 rats and BDF1 mice - drinking studies. In: Sumino, K. (Ed.), Proceedings, Second Asia-Pacific Symposium on Environmental and Occupational Health, International Center for Medical Research Kobe University School of Medicine, Kobe, pp. 193-198.